Sickle-cell thalassemia without crisis
ICD-10 D57.40 is a billable code used to indicate a diagnosis of sickle-cell thalassemia without crisis.
Sickle-cell thalassemia is a genetic blood disorder characterized by the presence of both sickle cell disease and thalassemia traits. Patients with this condition have abnormal hemoglobin, which can lead to hemolytic anemia due to the destruction of red blood cells. Unlike sickle cell disease, patients coded under D57.40 do not present with a crisis, which is a painful episode caused by the sickling of red blood cells that obstructs blood flow. The clinical manifestations of sickle-cell thalassemia can vary widely, depending on the severity of the thalassemia and the proportion of sickle hemoglobin. Symptoms may include fatigue, pallor, and episodes of pain, but without the acute complications associated with sickle cell crises. Genetic factors play a crucial role in this condition, as it is inherited in an autosomal recessive pattern. Diagnosis typically involves hemoglobin electrophoresis to identify the types of hemoglobin present. Management focuses on monitoring for complications, managing anemia, and providing supportive care.
Detailed lab results, genetic testing, and patient history.
Management of chronic anemia, monitoring for complications.
Ensure clarity in documentation regarding the absence of crisis.
Family history, genetic counseling notes, and test results.
Counseling families about inheritance patterns and risks.
Documenting the specific genetic mutations involved.
Used to monitor anemia in patients with sickle-cell thalassemia.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure that lab results are clearly linked to the diagnosis.
Sickle-cell thalassemia is a combination of sickle cell disease and thalassemia traits, leading to a different clinical presentation and management compared to sickle cell disease alone.
